Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma

Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma

BackgroundThe relationship between cuproptosis and HCC is still in the exploratory stage. Long noncoding RNAs (lncRNAs) have recently been linked to the progression of hepatocellular carcinoma (HCC). However, the clinical significance of lncRNAs associated with cuproptosis remains unclear.MethodsBas...

Full description

Bibliographic Details
Main Authors:	Wei Yuan, Jun-hao Xiao, Jian-song Zhang, Ben-liang Mao, Peng-zhen Wang, Bai-lin Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Oncology
Subjects:	AL590705.3 LINC02870 KDM4A-AS1 MKLN1-AS hepatocellular carcinoma immunological characteristics
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1153353/full

Similar Items

Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC
by: Xiao Jia, et al.
Published: (2023-12-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
by: Xilang Chen, et al.
Published: (2023-02-01)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
by: Yuezhi Zhu, et al.
Published: (2023-08-01)

Abnormal pattern of vitamin D receptor-associated genes and lncRNAs in patients with bipolar disorder
by: Reyhane Eghtedarian, et al.
Published: (2022-03-01)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
by: Chunhua Liu, et al.
Published: (2023-01-01)

Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk model
by: Jing He, et al.
Published: (2024-01-01)

Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853
by: Leifeng Chen, et al.
Published: (2023-04-01)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
by: Duguang Li, et al.
Published: (2023-01-01)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
by: Jiaying Liang, et al.
Published: (2021-06-01)

Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma
by: Junyou Zhu, et al.
Published: (2020-09-01)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
by: Xianbin Wu, et al.
Published: (2022-06-01)

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data
by: Yishuang Cui, et al.
Published: (2023-10-01)

Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma
by: Chen Li, et al.
Published: (2015-05-01)

A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma
by: Le-En Liao, et al.
Published: (2020-08-01)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
by: Shiyuan Qi, et al.
Published: (2023-04-01)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
by: Danjun Song, et al.
Published: (2023-03-01)

Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression
by: Zhonghou Rong, et al.
Published: (2020-04-01)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
by: Qi-Tong Xu, et al.
Published: (2023-01-01)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
by: YunZhen Peng, et al.
Published: (2022-08-01)

Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma
by: Wang WJ, et al.
Published: (2020-10-01)

Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma
by: Xigang Xia, et al.
Published: (2021-08-01)

Abnormal level of VDR-associated lncRNAs in patients with multiple sclerosis
by: Shahrokh Janamiri, et al.
Published: (2023-12-01)

Identification of Key lncRNA–mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data
by: Zhe Li, et al.
Published: (2021-08-01)

Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma
by: Zhong-Han Lou, et al.
Published: (2022-09-01)

Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma
by: Lixia Xu, et al.
Published: (2024-01-01)

The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective
by: Juan Pablo Unfried, et al.
Published: (2021-05-01)

Prognostic Signature of Hepatocellular Carcinoma and Analysis of Immune Infiltration Based on m6A-Related lncRNAs
by: Ting Guo, et al.
Published: (2021-08-01)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
by: Saiyidan Yalimaimaiti, et al.
Published: (2023-03-01)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
by: Hui Chen, et al.
Published: (2023-01-01)

Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value
by: Shehab-Eldeen S, et al.
Published: (2023-10-01)

Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
by: Xiaoyong Ge, et al.
Published: (2021-05-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Jingyi Wu, et al.
Published: (2023-09-01)

Delving into the Role of lncRNAs in Papillary Thyroid Cancer: Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion
by: Cristina Tous, et al.
Published: (2024-01-01)

Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma
by: Zunyi Zhang, et al.
Published: (2022-11-01)

Hypoxia-related LncRNAs signature predicts prognosis and is associated with immune infiltration and progress of head and neck squamous cell carcinoma
by: Minhan Li, et al.
Published: (2022-09-01)

LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression
by: Wei Zhou, et al.
Published: (2020-01-01)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
by: Shusheng Zhu, et al.
Published: (2023-07-01)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
by: Li Liu, et al.
Published: (2023-04-01)

Prognostic and immunological role of sulfatide-related lncRNAs in hepatocellular carcinoma
by: Xing Feng Huang, et al.
Published: (2023-02-01)